DividendJul 13, 2026, 05:31 PM
Cumberland Pharma Declares $1.50 Special Dividend; Authorizes $5M Buyback
AI Summary
Cumberland Pharmaceuticals Inc. declared a special cash dividend of $1.50 per share, payable around July 31, 2026, to shareholders of record on July 23, 2026. This decision follows a strategic transaction with Apotex Health Corp., which provided $100 million in cash and up to $11 million in additional payments, resulting in greater net cash than originally projected. The Board also authorized a new $5 million open-market share repurchase program, replacing the previous one with $2.1 million remaining, and several Board members plan to increase their holdings. The company will now focus on developing its ifetroban product candidates.
Key Highlights
- Declared a special cash dividend of $1.50 per share of common stock.
- Dividend payable on or about July 31, 2026, to shareholders of record as of July 23, 2026.
- Received $100 million in cash from the Apotex Health Corp. transaction.
- Expects up to $11 million in additional payments from Apotex for inventory and services.
- Authorized a new open-market share repurchase program of up to $5 million.
- Previous share repurchase program had $2.1 million remaining.
- Board members will establish new share purchase plans to increase holdings.
- Company will focus resources on developing ifetroban for rare diseases.
Price Impact
More from CPIX